Urinary Bladder Neoplasms (Bladder Cancer) Summary

Networked: 15177 relevant articles (973 outcomes, 2758 trials/studies) for this Disease

Key Drugs and Agents for Urinary Bladder Neoplasms

1. Cisplatin (Platino) : 79 outcomes 154 studies in 710 results : FDA 6 Generic
   
2. Mitomycin (Mitomycin-C) : 41 outcomes 89 studies in 374 results : FDA 7 Generic
   
3. gemcitabine : 33 outcomes 86 studies in 252 results : FDA 7
   
4. Epirubicin (Ellence) : 32 outcomes 53 studies in 150 results : FDA 13 Generic
   
5. Doxorubicin (Adriamycin) : 30 outcomes 72 studies in 390 results : FDA 12 Generic
   
6. Biological Markers (Surrogate Marker) : 18 outcomes 57 studies in 383 results : IBA
   
7. Methotrexate (Mexate) : 16 outcomes 51 studies in 231 results : FDA 8 Generic
   
8. Antigens : 13 outcomes 41 studies in 343 results : IBA
   
9. nuclear matrix protein 22 : 13 outcomes 27 studies in 140 results : IBA
   
10. Vinblastine (Vinblastine Sulfate) : 12 outcomes 35 studies in 153 results : FDA 7
    

Diseases Related to Urinary Bladder Neoplasms

1. Neoplasms (Cancer)
2. Urinary Bladder Neoplasms (Bladder Cancer)
3. Neoplasm Metastasis (Metastasis)
4. Carcinoma (Carcinomatosis)
5. Prostatic Neoplasms (Prostate Cancer)

Key Therapies for Urinary Bladder Neoplasms

1. Cystectomy : 175 outcomes 289 studies in 2874 results
   
2. Drug Therapy (Chemotherapy) : 159 outcomes 257 studies in 1685 results
   
3. Intravesical Administration : 58 outcomes 87 studies in 507 results
   
4. Immunotherapy : 57 outcomes 58 studies in 529 results
   
5. Radiotherapy : 47 outcomes 84 studies in 695 results